Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W1989604393', 'doi': 'https://doi.org/10.1111/j.1365-2141.2009.08008.x', 'title': 'The proteasome inhibitor CEP‐18770 enhances the anti‐myeloma activity of bortezomib and melphalan', 'display_name': 'The proteasome inhibitor CEP‐18770 enhances the anti‐myeloma activity of bortezomib and melphalan', 'publication_year': 2009, 'publication_date': '2009-12-02', 'ids': {'openalex': 'https://openalex.org/W1989604393', 'doi': 'https://doi.org/10.1111/j.1365-2141.2009.08008.x', 'mag': '1989604393', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/19958357'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/j.1365-2141.2009.08008.x', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2009.08008.x', 'source': {'id': 'https://openalex.org/S153015021', 'display_name': 'British Journal of Haematology', 'issn_l': '0007-1048', 'issn': ['0007-1048', '1365-2141'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2009.08008.x', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5090300095', 'display_name': 'Eric Sanchez', 'orcid': 'https://orcid.org/0000-0001-8656-3717'}, 'institutions': [{'id': 'https://openalex.org/I4210151813', 'display_name': 'Institute for Myeloma & Bone Cancer Research', 'ror': 'https://ror.org/04xwmf991', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210151813']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Eric Sanchez', 'raw_affiliation_strings': ['Institute for Myeloma & Bone Cancer Research, 9201 W. Sunset Boulevard, West Hollywood, CA 90069, USA.'], 'affiliations': [{'raw_affiliation_string': 'Institute for Myeloma & Bone Cancer Research, 9201 W. Sunset Boulevard, West Hollywood, CA 90069, USA.', 'institution_ids': ['https://openalex.org/I4210151813']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100416268', 'display_name': 'Mingjie Li', 'orcid': 'https://orcid.org/0000-0003-3470-1844'}, 'institutions': [{'id': 'https://openalex.org/I4210151813', 'display_name': 'Institute for Myeloma & Bone Cancer Research', 'ror': 'https://ror.org/04xwmf991', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210151813']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mingjie Li', 'raw_affiliation_strings': ['Institute for Myeloma & Bone Cancer Research, West Hollywood'], 'affiliations': [{'raw_affiliation_string': 'Institute for Myeloma & Bone Cancer Research, West Hollywood', 'institution_ids': ['https://openalex.org/I4210151813']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109452655', 'display_name': 'Jeffrey A. Steinberg', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210151813', 'display_name': 'Institute for Myeloma & Bone Cancer Research', 'ror': 'https://ror.org/04xwmf991', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210151813']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jeffrey A. Steinberg', 'raw_affiliation_strings': ['Institute for Myeloma & Bone Cancer Research, West Hollywood'], 'affiliations': [{'raw_affiliation_string': 'Institute for Myeloma & Bone Cancer Research, West Hollywood', 'institution_ids': ['https://openalex.org/I4210151813']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5111913118', 'display_name': 'Cathy Wang', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210151813', 'display_name': 'Institute for Myeloma & Bone Cancer Research', 'ror': 'https://ror.org/04xwmf991', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210151813']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Cathy Wang', 'raw_affiliation_strings': ['Institute for Myeloma & Bone Cancer Research, West Hollywood'], 'affiliations': [{'raw_affiliation_string': 'Institute for Myeloma & Bone Cancer Research, West Hollywood', 'institution_ids': ['https://openalex.org/I4210151813']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5009988932', 'display_name': 'Jing Shen', 'orcid': 'https://orcid.org/0000-0001-6157-8293'}, 'institutions': [{'id': 'https://openalex.org/I4210151813', 'display_name': 'Institute for Myeloma & Bone Cancer Research', 'ror': 'https://ror.org/04xwmf991', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210151813']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jing Shen', 'raw_affiliation_strings': ['Institute for Myeloma & Bone Cancer Research, West Hollywood'], 'affiliations': [{'raw_affiliation_string': 'Institute for Myeloma & Bone Cancer Research, West Hollywood', 'institution_ids': ['https://openalex.org/I4210151813']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055490703', 'display_name': 'Benjamin Bonavida', 'orcid': 'https://orcid.org/0000-0001-5594-2060'}, 'institutions': [{'id': 'https://openalex.org/I161318765', 'display_name': 'University of California, Los Angeles', 'ror': 'https://ror.org/046rm7j60', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I161318765']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Benjamin Bonavida', 'raw_affiliation_strings': ['Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, USA'], 'affiliations': [{'raw_affiliation_string': 'Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, CA, USA', 'institution_ids': ['https://openalex.org/I161318765']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100409070', 'display_name': 'Zhiwei Li', 'orcid': 'https://orcid.org/0000-0001-9366-9552'}, 'institutions': [{'id': 'https://openalex.org/I4210151813', 'display_name': 'Institute for Myeloma & Bone Cancer Research', 'ror': 'https://ror.org/04xwmf991', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210151813']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Zhi‐Wei Li', 'raw_affiliation_strings': ['Institute for Myeloma & Bone Cancer Research, West Hollywood'], 'affiliations': [{'raw_affiliation_string': 'Institute for Myeloma & Bone Cancer Research, West Hollywood', 'institution_ids': ['https://openalex.org/I4210151813']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100678208', 'display_name': 'Haiming Chen', 'orcid': 'https://orcid.org/0000-0003-3417-6103'}, 'institutions': [{'id': 'https://openalex.org/I4210151813', 'display_name': 'Institute for Myeloma & Bone Cancer Research', 'ror': 'https://ror.org/04xwmf991', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210151813']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Haiming Chen', 'raw_affiliation_strings': ['Institute for Myeloma & Bone Cancer Research, West Hollywood'], 'affiliations': [{'raw_affiliation_string': 'Institute for Myeloma & Bone Cancer Research, West Hollywood', 'institution_ids': ['https://openalex.org/I4210151813']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5040835019', 'display_name': 'James R. Berenson', 'orcid': 'https://orcid.org/0000-0003-1587-6104'}, 'institutions': [{'id': 'https://openalex.org/I4210151813', 'display_name': 'Institute for Myeloma & Bone Cancer Research', 'ror': 'https://ror.org/04xwmf991', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210151813']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James R. Berenson', 'raw_affiliation_strings': ['Institute for Myeloma & Bone Cancer Research, West Hollywood'], 'affiliations': [{'raw_affiliation_string': 'Institute for Myeloma & Bone Cancer Research, West Hollywood', 'institution_ids': ['https://openalex.org/I4210151813']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 4940, 'currency': 'USD', 'value_usd': 4940, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 5.422, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 77, 'citation_normalized_percentile': {'value': 0.910428, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '148', 'issue': '4', 'first_page': '569', 'last_page': '581'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10649', 'display_name': 'Multiple Myeloma Research and Treatments', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10649', 'display_name': 'Multiple Myeloma Research and Treatments', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11041', 'display_name': 'Ubiquitin and proteasome pathways', 'score': 0.9992, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12534', 'display_name': 'Protein Degradation and Inhibitors', 'score': 0.9986, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/melphalan', 'display_name': 'Melphalan', 'score': 0.93735456}], 'concepts': [{'id': 'https://openalex.org/C2777478702', 'wikidata': 'https://www.wikidata.org/wiki/Q419319', 'display_name': 'Bortezomib', 'level': 3, 'score': 0.9719924}, {'id': 'https://openalex.org/C2778684742', 'wikidata': 'https://www.wikidata.org/wiki/Q2298283', 'display_name': 'Melphalan', 'level': 3, 'score': 0.93735456}, {'id': 'https://openalex.org/C2776364478', 'wikidata': 'https://www.wikidata.org/wiki/Q467635', 'display_name': 'Multiple myeloma', 'level': 2, 'score': 0.8255118}, {'id': 'https://openalex.org/C2778367456', 'wikidata': 'https://www.wikidata.org/wiki/Q7251235', 'display_name': 'Proteasome inhibitor', 'level': 3, 'score': 0.6898747}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.6483198}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.6334251}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.355474}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.29692176}], 'mesh': [{'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D001897', 'descriptor_name': 'Boronic Acids', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D009101', 'descriptor_name': 'Multiple Myeloma', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D013912', 'descriptor_name': 'Threonine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017209', 'descriptor_name': 'Apoptosis', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D017209', 'descriptor_name': 'Apoptosis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001897', 'descriptor_name': 'Boronic Acids', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D001897', 'descriptor_name': 'Boronic Acids', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000069286', 'descriptor_name': 'Bortezomib', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016923', 'descriptor_name': 'Cell Death', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D016923', 'descriptor_name': 'Cell Death', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004353', 'descriptor_name': 'Drug Evaluation, Preclinical', 'qualifier_ui': 'Q000379', 'qualifier_name': 'methods', 'is_major_topic': False}, {'descriptor_ui': 'D004353', 'descriptor_name': 'Drug Evaluation, Preclinical', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004357', 'descriptor_name': 'Drug Synergism', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008558', 'descriptor_name': 'Melphalan', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D008558', 'descriptor_name': 'Melphalan', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D008558', 'descriptor_name': 'Melphalan', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016513', 'descriptor_name': 'Mice, SCID', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009101', 'descriptor_name': 'Multiple Myeloma', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D009101', 'descriptor_name': 'Multiple Myeloma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D061988', 'descriptor_name': 'Proteasome Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D011719', 'descriptor_name': 'Pyrazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013912', 'descriptor_name': 'Threonine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D013912', 'descriptor_name': 'Threonine', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D013912', 'descriptor_name': 'Threonine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014407', 'descriptor_name': 'Tumor Cells, Cultured', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D023041', 'descriptor_name': 'Xenograft Model Antitumor Assays', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/j.1365-2141.2009.08008.x', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2009.08008.x', 'source': {'id': 'https://openalex.org/S153015021', 'display_name': 'British Journal of Haematology', 'issn_l': '0007-1048', 'issn': ['0007-1048', '1365-2141'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/19958357', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/j.1365-2141.2009.08008.x', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2141.2009.08008.x', 'source': {'id': 'https://openalex.org/S153015021', 'display_name': 'British Journal of Haematology', 'issn_l': '0007-1048', 'issn': ['0007-1048', '1365-2141'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.79, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 42, 'referenced_works': ['https://openalex.org/W1495816485', 'https://openalex.org/W1844164142', 'https://openalex.org/W1907962006', 'https://openalex.org/W1938721925', 'https://openalex.org/W1963736485', 'https://openalex.org/W1968252950', 'https://openalex.org/W1984998337', 'https://openalex.org/W1986041760', 'https://openalex.org/W1993435599', 'https://openalex.org/W2010184965', 'https://openalex.org/W2024123206', 'https://openalex.org/W2026642838', 'https://openalex.org/W2028154024', 'https://openalex.org/W2029561750', 'https://openalex.org/W2037825770', 'https://openalex.org/W2043103956', 'https://openalex.org/W2045927984', 'https://openalex.org/W2047650149', 'https://openalex.org/W2053875306', 'https://openalex.org/W2060929578', 'https://openalex.org/W2061194648', 'https://openalex.org/W2077247713', 'https://openalex.org/W2077945404', 'https://openalex.org/W2081206502', 'https://openalex.org/W2084842992', 'https://openalex.org/W2103562758', 'https://openalex.org/W2107154392', 'https://openalex.org/W2108235071', 'https://openalex.org/W2121411022', 'https://openalex.org/W2126267349', 'https://openalex.org/W2129890171', 'https://openalex.org/W2131915887', 'https://openalex.org/W2138102966', 'https://openalex.org/W2142149038', 'https://openalex.org/W2152065071', 'https://openalex.org/W2153356756', 'https://openalex.org/W2158794607', 'https://openalex.org/W2168458127', 'https://openalex.org/W2186387606', 'https://openalex.org/W2327251173', 'https://openalex.org/W2547188540', 'https://openalex.org/W66356296'], 'related_works': ['https://openalex.org/W3032571198', 'https://openalex.org/W3029266790', 'https://openalex.org/W3028919400', 'https://openalex.org/W2419203554', 'https://openalex.org/W2416181646', 'https://openalex.org/W2411542114', 'https://openalex.org/W2392801617', 'https://openalex.org/W2089743544', 'https://openalex.org/W2063424779', 'https://openalex.org/W1989604393'], 'abstract_inverted_index': {'Summary': [0], 'The': [1, 95], 'anti‐multiple': [2], 'myeloma': [3], '(MM)': [4], 'efficacy': [5, 30], 'of': [6, 13, 31, 67, 80, 89, 97, 105, 112, 144, 151], 'bortezomib': [7, 63, 101], 'has': [8, 21, 50], 'led': [9], 'to': [10, 83, 116], 'the': [11, 29, 78, 87, 149], 'development': [12, 143], 'other': [14], 'proteasome': [15], 'inhibitors': [16], '(PI),': [17], 'including': [18], 'CEP‐18770': [19, 38, 58, 81, 98, 124], 'which': [20], 'shown': [22], 'anti‐MM': [23, 48, 129], 'effects': [24, 130], 'in': [25, 39, 44, 71, 131, 148], 'preclinical': [26, 139], 'studies.': [27], 'However,': [28], 'orally': [32], '(PO)': [33], 'or': [34, 62, 163], 'intravenously': [35], '(IV)': [36], 'administered': [37], 'multiple': [40], 'MM': [41, 68, 75, 152], 'models': [42], 'and': [43, 92, 100, 108], 'combination': [45, 96], 'with': [46, 60, 118, 160], 'conventional': [47], 'therapies': [49], 'not': [51], 'been': [52], 'evaluated.': [53], 'Herein,': [54], 'we': [55], 'show': [56], 'that': [57], 'combined': [59, 159], 'melphalan': [61, 84, 162], 'induces': [64], 'synergistic': [65], 'inhibition': [66], 'cell': [69], 'viability': [70], 'vitro': [72], '.': [73], 'In': [74], 'xenograft': [76, 133], 'models,': [77], 'addition': [79], 'IV': [82, 99], 'completely': [85], 'prevented': [86], 'growth': [88], 'both': [90], 'melphalan‐sensitive': [91], 'melphalan‐resistant': [93], 'tumours.': [94], 'induced': [102], 'complete': [103], 'regression': [104], 'bortezomib‐sensitive': [106], 'tumours': [107, 114], 'markedly': [109], 'delayed': [110], 'progression': [111], 'bortezomib‐resistant': [113], 'compared': [115], 'treatment': [117, 150], 'either': [119, 161], 'agent': [120, 123], 'alone.': [121], 'Single': [122], 'PO': [125], 'also': [126], 'showed': [127], 'marked': [128], 'these': [132], 'models.': [134], 'These': [135], 'studies': [136], 'provide': [137], 'strong': [138], 'rationale': [140], 'for': [141], 'further': [142], 'this': [145], 'novel': [146], 'PI': [147], 'as': [153, 156, 158], 'a': [154], 'monotherapy': [155], 'well': [157], 'bortezomib.': [164]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1989604393', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 1}, {'year': 2021, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 5}, {'year': 2019, 'cited_by_count': 5}, {'year': 2018, 'cited_by_count': 2}, {'year': 2017, 'cited_by_count': 6}, {'year': 2016, 'cited_by_count': 3}, {'year': 2015, 'cited_by_count': 4}, {'year': 2014, 'cited_by_count': 6}, {'year': 2013, 'cited_by_count': 11}, {'year': 2012, 'cited_by_count': 18}], 'updated_date': '2024-12-14T06:04:34.853091', 'created_date': '2016-06-24'}